Turi, K.N.; McKennan, C.; Rosas-Salazar, C.; Gebretsedik, T.; Newcomb, D.C.; Thompson, E.E.; Gern, J.; Chappell, J.; Anderson, L.; Ober, C.;
et al. Association of 17q12-q21 Asthma Risk Locus with Clinical Severity of Infant Respiratory Syncytial Virus Infection. Biomolecules 2025, 15, 1056.
https://doi.org/10.3390/biom15081056
AMA Style
Turi KN, McKennan C, Rosas-Salazar C, Gebretsedik T, Newcomb DC, Thompson EE, Gern J, Chappell J, Anderson L, Ober C,
et al. Association of 17q12-q21 Asthma Risk Locus with Clinical Severity of Infant Respiratory Syncytial Virus Infection. Biomolecules. 2025; 15(8):1056.
https://doi.org/10.3390/biom15081056
Chicago/Turabian Style
Turi, Kedir N., Christopher McKennan, Christian Rosas-Salazar, Tebeb Gebretsedik, Dawn C. Newcomb, Emma E. Thompson, James Gern, James Chappell, Larry Anderson, Carole Ober,
and et al. 2025. "Association of 17q12-q21 Asthma Risk Locus with Clinical Severity of Infant Respiratory Syncytial Virus Infection" Biomolecules 15, no. 8: 1056.
https://doi.org/10.3390/biom15081056
APA Style
Turi, K. N., McKennan, C., Rosas-Salazar, C., Gebretsedik, T., Newcomb, D. C., Thompson, E. E., Gern, J., Chappell, J., Anderson, L., Ober, C., & Hartert, T.
(2025). Association of 17q12-q21 Asthma Risk Locus with Clinical Severity of Infant Respiratory Syncytial Virus Infection. Biomolecules, 15(8), 1056.
https://doi.org/10.3390/biom15081056
